No Detail Found!

Can living donor liver transplantation offer similar outcomes to deceased donor liver transplantation using expanded selection criteria for hepatocellular carcinoma?

Author(s)
Li-Ping Chen Department of Biliary Surgery, West China Hospital of Sichuan University, Chengdu, China
Chuan Li Department of Liver Surgery & Liver Transplantation, West China Hospital of Sichuan University, Chengdu, China
Tian-Fu Wen Department of Liver Surgery & Liver Transplantation, West China Hospital of Sichuan University, Chengdu, China
Lu-Nan Yan Department of Liver Surgery & Liver Transplantation, West China Hospital of Sichuan University, Chengdu, China
Bo Li Department of Liver Surgery & Liver Transplantation, West China Hospital of Sichuan University, Chengdu, China
Jia-Yin Yang Department of Liver Surgery & Liver Transplantation, West China Hospital of Sichuan University, Chengdu, China
Abstract
Objective: To compare the outcomes of living donor liver transplantation (LDLT) versus deceased donor liver transplantation (DDLT) for patients with hepatocellular carcinoma (HCC) in different selection criteria. Methods: Data of patients with HCC who underwent liver transplantation between 2005 and 2013 at our center were reviewed. Clinical data of LDLT recipients and DDLT recipients were compared. The postoperative recurrence-free survival (RFS) rate and overall survival (OS) rate after LDLT versus DDLT were compared in the Milan recipients, the University of California, San Francisco (UCSF) recipients, the up-to-seven recipients, the Hangzhou recipients and the Chengdu recipients. Results: Data of 255 patients were retrospectively reviewed in this study. Seventeen DDLT recipient and 9 LDLT recipients died during the perioperative period. Among the remaining 229 recipients (NLDLT=66, NDDLT=163), 96 patients met the Milan criteria, 123 recipients met the UCSF criteria, 135 patients met the up-to-seven criteria, 216 patients met the Hangzhou criteria, and 229 recipients met the Chengdu criteria. The overall RFS and OS rates of the Milan recipients, the UCSF recipients, the up-to-seven recipients, the Hangzhou recipients and the Chengdu recipients after LDLT and DDLT were all similar. Conclusion: Using well-studied selection criteria, LDLT offers similar outcomes to DDLT for patient with HCC, even using expanded selection criteria.
Publication Details
Page(s) 763-769
DOI DOI not available
Published Journal: Pakistan Journal of Medical Sciences, Volume: 31, Issue: 4, Year: 2015

Request the full text from PASTIC

0

Citations

0

Downloads

79

Views